ArticleTherapeutic advances in psychopharmacology2016

A randomized, double-blind, cross-over, phase IV trial of oros-methylphenidate (CONCERTA(®)) and generic novo-methylphenidate ER-C (NOVO-generic).

Angelo Fallu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.